These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 31933129

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Alternative carriers in dry powder inhaler formulations.
    Rahimpour Y, Kouhsoltani M, Hamishehkar H.
    Drug Discov Today; 2014 May; 19(5):618-26. PubMed ID: 24269834
    [Abstract] [Full Text] [Related]

  • 43. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM, Mescher A, Schroettner H, Achelis L, Walzel P, Urbanetz NA.
    Eur J Pharm Biopharm; 2012 Sep; 82(1):194-204. PubMed ID: 22595133
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A, Riddell K, Joshi S, Chan R, Mehta R.
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [Abstract] [Full Text] [Related]

  • 47. Performance tuning of particle engineered mannitol in dry powder inhalation formulations.
    Hertel N, Birk G, Scherließ R.
    Int J Pharm; 2020 Aug 30; 586():119592. PubMed ID: 32622814
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Spherical agglomerates of lactose as potential carriers for inhalation.
    Zellnitz S, Lamešić D, Stranzinger S, Pinto JT, Planinšek O, Paudel A.
    Eur J Pharm Biopharm; 2021 Feb 30; 159():11-20. PubMed ID: 33358941
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
    Zhong Q.
    AAPS PharmSciTech; 2018 Feb 30; 19(2):531-540. PubMed ID: 28840529
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition.
    Sun Y, Qin L, Liu C, Su J, Zhang X, Yu D, Guo C, Lu H, Li L, Xiong W, Mao S.
    Int J Pharm; 2020 Feb 15; 575():119000. PubMed ID: 31893544
    [Abstract] [Full Text] [Related]

  • 58. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
    Li J, Ma S, He X, Sun Y, Zhang X, Guan J, Mao S.
    Int J Pharm; 2023 Jul 25; 642():123179. PubMed ID: 37364785
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.